Stroke Prevention
James Lee, Pharm.D., BCACP Feedback, suggestions, and comments? Contact the Page Manager: James...
Read More
Tag: Stroke Prevention
But It’s Just Baby Aspirin: Reconsidering Low-Dose Aspirin USE for Primary Prevention
New data published in the past 3 years alters the United States Preventive Services Task Force (USPSTF) recommendations.
Read More
Can a Polypill ‘TIP’ the Scale to a One-Size-Fits All Approach?
Given that pill burden and medication cost are an increasing problem, would our patients benefit from a simple, low-cost, one-size-fits-all approach to addressing cardiovascular risk?
Read More
Using Shared Decision-Making Tools: Are They Worth It?
There’s no denying that shared decision making (SDM) is an effective communication approach for making patient-centered medical decisions. But studies have yielded mixed results with regard to patient outcomes.
Read More
Can VOYAGER Put PAD Patients Back on Their Feet?
The VOYAGER PAD trial was the largest trial conducted in patients with PAD following a recent revascularization procedure.
Read MoreSecondary Stroke Prevention in A-Fib: Do DOACs PROSPER in High-Risk Patients?
The PROSPER study provides important new insights into the benefits and risks of DOACs in older adults (median age = 80 years!) following a cardioembolic stroke due to a-fib.
Read More
Pioglitazone After Ischemic Stroke or TIA – IRIS Study Critically Examined
The Insulin Resistance Intervention after Stroke (IRIS) trial examined the benefits and risks of pioglitazone use after a recent ischemic stroke or TIA.
Read More
Loading ...About
iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.